Sports bioeconomy
Wearables, blood panels and at-home biomarker tests that turn an athlete's own physiology — recovery, blood chemistry, glucose, genetics, urine biomarkers — into an actionable training signal, sold direct-to-consumer as a performance product rather than a clinical diagnostic.
1 · What it gives
Sports bioeconomy covers the wearables, blood panels, genetic tests and at-home biomarker kits that turn an athlete’s own physiology into an actionable training signal, sold direct-to-consumer as a performance and recovery product rather than routed through a clinical diagnostic pathway. A modern recovery wearable derives daily readiness scores from continuously measured biomarkers (heart-rate variability, respiratory rate, skin temperature), while an at-home blood panel service tests dozens of biomarkers from a single draw and translates the results into specific training and nutrition recommendations. The category spans wearable recovery tracking, blood-panel performance testing, genetic tests linking specific gene variants to nutrition and training response, continuous glucose monitoring adapted from diabetes care to athletic fueling, and urine biomarker strips paired with a smartphone app for daily wellness tracking. Because these products are marketed and regulated as wellness or performance tools rather than medical devices, the category occupies a distinct regulatory and commercial lane from clinical diagnostics, even where the underlying biomarker assay technology overlaps.
The key directions of sports bioeconomy are:
- Wearable recovery and readiness tracking: continuous biomarker measurement (heart-rate variability, respiratory rate, skin temperature) generates a daily recovery and readiness score without a blood draw.
- Blood-panel performance testing: at-home or lab blood-draw services test dozens of biomarkers and translate results into specific training, nutrition and supplementation recommendations.
- Genetic testing for nutrition and training response: DNA tests link specific gene variants to individual nutrition and exercise-response profiles, informing personalized training and diet plans.
- Continuous glucose and urine biomarker monitoring: technology adapted from diabetes care (continuous glucose monitors) and at-home diagnostics (urine test strips) is repositioned for athletic fueling and daily wellness tracking.
Sectoral value chain#
[Athlete biomarker source] ──> [Measurement device/assay] ──> [Data collection]
│
(biomarker interpretation)
│
▼
[Training/nutrition recommendation] <─── [App/platform delivery] <─── [Personalized analysis]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Device/assay manufacturing | Wearable sensors, blood-panel test kits, genetic-test kits or urine test strips are manufactured to a defined measurement specification. | In: sensor/assay components. Out: manufactured measurement device or kit. |
| Sample/signal collection | The athlete wears the device continuously or provides a blood, saliva or urine sample. | In: manufactured device/kit, athlete. Out: raw biomarker signal or sample. |
| Biomarker measurement | The device or laboratory processes the signal or sample into calibrated biomarker values. | In: raw signal/sample. Out: calibrated biomarker data. |
| Personalized analysis | Algorithms or lab interpretation translate biomarker data into an individual recovery score, nutrition profile or training recommendation. | In: calibrated biomarker data, individual baseline. Out: personalized interpretation. |
| App/platform delivery | The personalized analysis is delivered to the athlete through a mobile app or web platform. | In: personalized interpretation. Out: athlete-facing recommendation. |
| Training/nutrition action | The athlete adjusts training load, nutrition or recovery behavior based on the delivered recommendation. | In: athlete-facing recommendation. Out: modified training/nutrition behavior. |
Cross-cutting technologies of the sector:
- Continuous wearable biomarker sensing: heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without requiring a blood draw, enabling continuous rather than point-in-time measurement.
- Direct-to-consumer blood-panel testing: at-home or retail blood-draw services test dozens of biomarkers in a single panel, translating lab results directly into consumer-facing training and nutrition guidance.
- Repositioned diagnostic technology: continuous glucose monitors developed for diabetes management and urine test strips developed for clinical screening are repositioned as athletic performance and wellness tools for a non-clinical consumer market.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Device/assay manufacturingTesting & analyticsContract manufacturing (CMO/CDMO)Wearable sensors, blood-panel test kits, genetic-test kits or urine test strips are manufactured to a defined measurement specification.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”450,000 tons/year“They control the entire life cycle from feed to processing and emphasize sustainable practices and B2B OEM/private-label growth alongside the Sa Giang consumer brand.”Cell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”Sumitomo Chemical Japan“Health & Crop Sciences / Data & Energy Materials: data-oriented chemistry and energy/function materials; Advanced Medical Solutions includes CDMO activities for advanced small …”Metso Finland“Metso OEM parts are designed to fit and function 100%.”
- 2Sample/signal collectionThe athlete wears the device continuously or provides a blood, saliva or urine sample.
- 3Biomarker measurementTesting & analyticsThe device or laboratory processes the signal or sample into calibrated biomarker values.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Vaxxinova Norway Norwayindustrial scale“Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.”KPP Powers Commodities Inc Philippines“Products are released with a certificate of analysis provided and tested by Qualibet Testing Services Corporation.”
- 4Personalized analysisTesting & analyticsAlgorithms or lab interpretation translate biomarker data into an individual recommendation.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Vaxxinova Norway Norwayindustrial scale“Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.”KPP Powers Commodities Inc Philippines“Products are released with a certificate of analysis provided and tested by Qualibet Testing Services Corporation.”
- 5App/platform deliveryThe personalized analysis is delivered to the athlete through a mobile app or web platform.
- 6Training/nutrition action
The athlete adjusts training load, nutrition or recovery behavior based on the delivered recommendation.
4 · Who delivers
Matched suppliers (matched automatically)
| Euphoria Retreat | Greece | Services / consulting | active |
| Esco Aster | Singapore | Services / consulting | active |
| BioCC LLC | Estonia | Research / RTO | active |
| Renovo Bioeconomy S.p.A. | Italy | Producer | active |
| Zoetis | United States | Producer | active |
| Recursion Pharmaceuticals | United States | Research / RTO | active |
| EcoTechnilin | France | Producer | active |
| Matís Iceland | Iceland | Research / RTO | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| WHOOP | 🇺🇸 USA | Recovery/performance and cardiovascular biomarker tracking | Continuous wearable HRV, respiratory rate, skin temperature | Commercial |
| InsideTracker | 🇺🇸 USA | Ultimate blood-panel membership | At-home/mobile blood draw, dozens of biomarkers | Commercial |
| Nutrigenomix | 🇨🇦 Canada | Athlete-focused genetic nutrition test | Gene-variant-based nutrition/training-response profiling | Commercial |
| Supersapiens | 🇺🇸 USA | Continuous glucose monitoring for athletes | Diabetes-sensor technology repositioned for athletic fueling | Commercial |
| Vivoo | 🇺🇸 USA | 9-in-1 urine wellness test | Smartphone-app-paired daily biomarker tracking | Commercial |
5 · Rules & route to market
United States
The US hosts the leading wearable recovery-tracking company, an at-home blood-panel testing pioneer, a continuous-glucose-monitoring athletic performance company and a urine-biomarker wellness-testing company.
wearable recovery tracking, blood-panel testing, repositioned diagnostic technology#
- WHOOP: publishes dedicated content on recovery and performance biomarkers and cardiovascular biomarkers for athletes, positioning continuous wearable measurement specifically around training and heart-health guidance.
- InsideTracker: offers at-home and mobile blood-draw testing with an “Ultimate” membership tier, an established direct-to-consumer blood-panel testing pioneer in the category.
- Supersapiens: built the first continuous glucose-monitoring system specifically for athletic performance, repositioning diabetes-care sensor technology for non-clinical athletic fueling.
- Vivoo: offers a 9-in-1 urine test paired with a smartphone app tracking hydration, pH balance, ketone levels and other wellness biomarkers for daily use.
European Union
This screening round did not confirm a European-headquartered sports bioeconomy company with on-domain evidence distinct from candidates checked elsewhere; the category currently reads as concentrated among US-headquartered wearable, blood-panel and diagnostic-repositioning companies.
screening limitation#
- Screening note: a UK-based sweat-testing candidate returned confirming evidence only through third-party competitor content rather than its own domain — a false-confirmation, dropped rather than tabled.
China
No China-headquartered sports bioeconomy company cleared this screening round with confirmed, on-domain evidence.
import- and distributor-served market#
- Screening note: one candidate China-headquartered sports biomarker company was probed and did not return confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed.
6 · Money: tenders & grants
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 326 days |
| Grant | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · United States | Jul 5, 2029 955 days |
| Grant | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States | Aug 18, 2027 268 days |
| Grant | Capacity building for extending product lifecycles through repair and refurbishment European Commission · EU | Sep 22, 2027 303 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 428 days |
7 · Tech stack & innovations
The stack layers continuous wearable sensing, direct-to-consumer lab testing and repositioned clinical-diagnostic technology on a common personalized-performance backbone.
- Continuous wearable biomarker sensing:
- Heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without a blood draw, enabling continuous rather than point-in-time measurement.
- Dedicated cardiovascular and recovery-biomarker content packages the underlying sensor data into athlete-facing training and heart-health guidance.
- Direct-to-consumer blood-panel and genetic testing:
- At-home or mobile blood-draw services test dozens of biomarkers in one panel, translating lab results into consumer-facing recommendations without a clinical visit.
- Gene-variant testing links an athlete’s genetics to individual nutrition and training-response profiles, personalizing recommendations beyond what a one-size-fits-all blood panel alone provides.
- Repositioned diagnostic technology for athletic use:
- Continuous glucose monitors, originally developed for diabetes management, are repositioned as athletic fueling tools for a non-clinical consumer market.
- Urine test strips paired with a smartphone app extend at-home diagnostic technology into daily wellness tracking outside a clinical screening context.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Whoop producer checked 2026-07-30 · link not kept
- Insidetracker producer checked 2026-07-29 · link not kept
- Nutrigenomix producer checked 2026-05-27 · link not kept
- Supersapiens producer checked 2026-05-21 · link not kept
- Vivoo producer checked 2026-08-05 · link not kept